scholarly journals Short-term changes of blood pressure and aortic stiffness in older patients after transcatheter aortic valve implantation

2019 ◽  
Vol Volume 14 ◽  
pp. 1379-1386
Author(s):  
Jeannette A Goudzwaard ◽  
Eleonora Disegna ◽  
Marjo JAG de Ronde-Tillmans ◽  
Mattie J Lenzen ◽  
Peter PT de Jaegere ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Older Patients ◽  
Aortic Stiffness ◽  
Short Term ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

P18 AORTIC STIFFNESS IN AORTIC STENOSIS: SHORT TERM HEMODYNAMIC CHANGES AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION

2018 ◽  
Vol 24 (C) ◽  
pp. 85
Author(s):  
Jeannette Goudzwaard ◽  
Nahid El Faquir ◽  
Nicolas van Mieghem ◽  
Marjo de Ronde-Tillmans ◽  
Mattie Lenzen ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Transcatheter Aortic Valve Implantation ◽  
Aortic Stiffness ◽  
Hemodynamic Changes ◽  
Short Term ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Kidney dysfunction and short term all-cause mortality after transcatheter aortic valve implantation

2020 ◽  
Vol 81 ◽  
pp. 32-37 ◽  
Author(s):  
Fabio Alfredo Sgura ◽  
Salvatore Arrotti ◽  
Paolo Magnavacchi ◽  
Daniel Monopoli ◽  
Davide Gabbieri ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Kidney Dysfunction ◽  
Short Term ◽  
Transcatheter Aortic Valve ◽  
All Cause Mortality ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Single-Center Experience and Short-term Outcome with the JenaValve: A Second-Generation Transapical Transcatheter Aortic Valve Implantation Device

2014 ◽  
Vol 9 (5) ◽  
pp. 368-374 ◽  
Author(s):  
Oliver Reuthebuch ◽  
Devdas Thomas Inderbitzin ◽  
Florian Ruter ◽  
Raban Jeger ◽  
Christoph Kaiser ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Second Generation ◽  
Short Term ◽  
Term Outcome ◽  
Transcatheter Aortic Valve ◽  
Short Term Outcome ◽  
The Mean ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Objective We present the post-CE(Conformité Européenne)-mark single-center implantation experience and short-term outcome with the second-generation transapical JenaValve transcatheter aortic valve implantation system. Methods Patients [N = 27; 9 women; mean (SD) age, 80.3 (5.5) years] were operated on between November 2011 and August 2012. Via a transapical approach, the valve was positioned, in some cases, repositioned, and finally implanted. All data were collected during the hospital stay. Results The implantation success rate was 100%; the mean (SD) operation time was 124.7 (43.2) minutes; and the size of the implanted prosthesis was 23 mm (n = 6), 25 mm (n = 14), and 27 mm (n = 7). The in-hospital major adverse cardiac and cerebrovascular events were as follows: intraoperative resuscitation with subsequent aortic rupture (n = 1), postoperative hemorrhage needing revision (n = 1), myocardial infarction (n = 1), atrioventricular block needing a definitive pacemaker (n = 1), new-onset renal failure needing hemodialysis (n = 1), and stroke (n = 1). The 30-day mortality was 11.1% (n = 3). The mean (SD) intensive care unit/total stay was 2.2 (1.7)/11.7 (7.9) days. Postoperative echocardiography [day 6.7 (4.8)] revealed residual para-valvular leakage of trace to grade 1 in 12 patients (44.5%) and no leakage in 15 patients, with a mean (SD) transvalvular pressure gradient of 11.6 (5.6) mm Hg with significant reduction by 36.0 (17.7) mm Hg ( P = 0.0001, Wilcoxon signed rank test). Conclusions This second-generation repositionable transcatheter aortic valve implantation device could safely and successfully be implanted with a fast learning curve, significant reduction in pressure gradients, overall clinical improvement at discharge, as well as an acceptable morbidity and mortality rate in this highest-risk patient cohort.

Short-term pacemaker dependency after transcatheter aortic valve implantation

2016 ◽  
Vol 128 (5-6) ◽  
pp. 198-203 ◽  
Author(s):  
Christiana Schernthaner ◽  
Johannes Kraus ◽  
Franz Danmayr ◽  
Matthias Hammerer ◽  
Jens Schneider ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Short Term ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Incidence, determinants and consequences of delirium in older patients after transcatheter aortic valve implantation

2020 ◽  
Vol 49 (3) ◽  
pp. 389-394 ◽  
Author(s):  
Jeannette A Goudzwaard ◽  
Marjo J A G de Ronde-Tillmans ◽  
Tom A J de Jager ◽  
Mattie J Lenzen ◽  
Rutger-Jan Nuis ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Older Patients ◽  
Mortality Data ◽  
Transcatheter Aortic Valve ◽  
Procedural Time ◽  
Aortic Valve Implantation ◽  
One Year ◽  
Valve Implantation ◽  
Negative Health Outcomes

Abstract Background delirium is an event leading to negative health outcomes and increased mortality in patients. The aim of this study is to investigate the incidence, determinants and consequences of post-operative delirium (POD) in older patients undergoing transcatheter aortic valve implantation (TAVI). Methods The TAVI Care and Cure program is a prospective, observational registry in patients referred for TAVI at Erasmus University Medical Centre. The presence of delirium was evaluated by daily clinical assessment by a geriatrician pre- and up to 3 days post-TAVI. Mortality data were obtained from the Dutch Civil Registry. Results A total of 543 patients underwent TAVI between January 2014 and December 2017. Overall, the incidence of POD was 14% (75/543 patients) but declined from 18% in 2014 to 7% in 2017 (P = 0.009). Patients who developed POD were older (81.9 ± 5.8 versus 78.6 ± 8.3 years, P < 0.001), had higher prevalence of renal dysfunction and prior stroke (54% versus 40%, P = 0.02; 31% versus 18%, P = 0.01) and were more often frail (32% versus 25%, P = 0.02). From a procedural perspective, general anesthesia (odds ratios (OR), 2.31; 95% CI, 1.40–3.83; P = 0.001), non-transfemoral access (OR, 2.37; 95% CI, 1.20–4.70; P = 0.01) and longer procedural time (OR, 1.01; 95% CI, 1.01–1.02; P < 0.001) were significantly associated with POD. One-year survival rate was 68% among patients who had suffered a POD and was 85% in patients without a POD (hazard ratio’s 1.8 (95% CI 1.01–3.10), P = 0.045). Conclusion POD frequently occurs after TAVI and is associated with increased mortality. It might be speculated that patient selection and the minimalistic approach of TAVI may reduce the frequency of delirium.

Sign in / Sign up

Export Citation Format

Share Document